Lv5
1150 积分 2023-05-04 加入
A systematic review of salvage therapies in refractory metastatic colorectal cancer
20天前
已完结
Sintilimab plus bevacizumab, oxaliplatin and capecitabine as first-line therapy in RAS-mutant, microsatellite stable, unresectable metastatic colorectal cancer: an open-label, single-arm, phase II trial
1个月前
已完结
Regorafenib in patients with metastatic colorectal cancer in Spain: from clinical trials to real-world evidence
2个月前
已完结
Immunotherapy combined with cranial radiotherapy for driver-negative non-small-cell lung cancer brain metastases: a retrospective study
2个月前
已完结
Immunotherapy combined with cranial radiotherapy for driver-negative non-small-cell lung cancer brain metastases: a retrospective study
2个月前
已关闭
Gastric cancer
4个月前
已完结
Upfront FOLFOXIRI plus bevacizumab with or without atezolizumab in the treatment of patients with metastatic colorectal cancer (AtezoTRIBE): a multicentre, open-label, randomised, controlled, phase 2 trial
4个月前
已完结
Targeted Therapies in Advanced Gastric Cancer
5个月前
已完结
Colorectal cancer
8个月前
已完结
Trastuzumab emtansine versus taxane use for previously treated HER2-positive locally advanced or metastatic gastric or gastro-oesophageal junction adenocarcinoma (GATSBY): an international randomised, open-label, adaptive, phase 2/3 study
8个月前
已完结
皖公网安备34019202002308
